CVE-2016-6028
IBM Jazz technology based products might allow an attacker to view work item titles that they do...
IBM Jazz technology based products might allow an attacker to view work item titles that they do not have privilege to view.
Attack profile
How easy it is to exploit
- Attack vector
- Network
- Complexity
- Low
- Privileges needed
- Low
- User interaction
- None
What an attacker can affect
- Confidentiality
- Low
- Integrity
- None
- Availability
- None
Exploit likelihood
What each source reports
NVD Score used
IBM Jazz technology based products might allow an attacker to view work item titles that they do not have privilege to view.
- Record
CVE-2016-6028- CVSS 3.0
- 4.3 Medium
CVSS:3.0/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:N/A:N - CVSS 2.0
- 4.0 Medium
AV:N/AC:L/Au:S/C:P/I:N/A:N - Weakness
- CWE-264
- Updated
- 2026-11-02
CVE List No score
IBM Jazz technology based products might allow an attacker to view work item titles that they do not have privilege to view.
- Record
CVE-2016-6028- Updated
- 2026-11-02
EUVDEUVD-2016-6962 No score
IBM Jazz technology based products might allow an attacker to view work item titles that they do not have privilege to view.
- Record
EUVD-2016-6962- Updated
- 2026-11-03
GitHub AdvisoriesGHSA-695x-3gmc-3vj9
IBM Jazz technology based products might allow an attacker to view work item titles that they do...
IBM Jazz technology based products might allow an attacker to view work item titles that they do not have privilege to view.
- Record
GHSA-695x-3gmc-3vj9- CVSS 3.0
- 4.3 Medium
CVSS:3.0/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:N/A:N - Updated
- 2026-11-02
Affected products
History
| Recorded | Changed | Sources |
|---|---|---|
| aliases, products | EUVD | |
| first indexed | CVE List, GitHub Advisories, NVD |
Dates are when Every CVE recorded each change. Upstream dates may differ.
In short
CVE-2016-6028 is a medium vulnerability (CVSS 4.3) in Ibm Rational Collaborative Lifecycle Management, published February 1, 2017. No source lists public exploit code. EPSS puts the chance of exploitation in the next 30 days at 0.77%, the 55th percentile. No source names a fixed version.